Clinical Outcomes of Diabetic Ketoacidosis in Type 2 Diabetes Patients with and without SGLT2 Inhibitor Treatment: A Retrospective Study.

Afif NakhlehAreen OthmanAmin MasriMoshe ZloczowerSagit ZolotovNaim Shehadeh

Published in: Biomedicines (2023)

T2DM patients with DKA who received SGLT2 inhibitors had lower long-term mortality from any cause compared to those who did not receive SGLT2 inhibitors.

Keyphrases

type diabetes
glycemic control
cardiovascular events
cardiovascular disease
insulin resistance
risk factors
metabolic syndrome
adipose tissue
skeletal muscle
coronary artery disease